237 related articles for article (PubMed ID: 10610624)
1. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
[TBL] [Abstract][Full Text] [Related]
2. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.
Waldman SA; Cagir B; Rakinic J; Fry RD; Goldstein SD; Isenberg G; Barber M; Biswas S; Minimo C; Palazzo J; Park PK; Weinberg D
Dis Colon Rectum; 1998 Mar; 41(3):310-5. PubMed ID: 9514425
[TBL] [Abstract][Full Text] [Related]
3. Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.
Waldman SA; Hyslop T; Schulz S; Barkun A; Nielsen K; Haaf J; Bonaccorso C; Li Y; Weinberg DS
JAMA; 2009 Feb; 301(7):745-52. PubMed ID: 19224751
[TBL] [Abstract][Full Text] [Related]
4. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
Chen G; McIver CM; Texler M; Lloyd JM; Rieger N; Hewett PJ; Sen Wan D; Hardingham JE
Dis Colon Rectum; 2004 May; 47(5):679-86. PubMed ID: 15037935
[TBL] [Abstract][Full Text] [Related]
5. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.
Bustin SA; Siddiqi S; Ahmed S; Hands R; Dorudi S
Int J Cancer; 2004 Jan; 108(3):412-7. PubMed ID: 14648708
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y
Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822
[TBL] [Abstract][Full Text] [Related]
7. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
Schulz S; Hyslop T; Haaf J; Bonaccorso C; Nielsen K; Witek ME; Birbe R; Palazzo J; Weinberg D; Waldman SA
Clin Cancer Res; 2006 Aug; 12(15):4545-52. PubMed ID: 16899600
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
Conzelmann M; Dieterle CP; Linnemann U; Berger MR
Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
[TBL] [Abstract][Full Text] [Related]
9. Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.
Fava TA; Desnoyers R; Schulz S; Park J; Weinberg D; Mitchell E; Waldman SA
J Clin Oncol; 2001 Oct; 19(19):3951-9. PubMed ID: 11579116
[TBL] [Abstract][Full Text] [Related]
10. Previstage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer.
Carlson MR
Mol Diagn Ther; 2009; 13(1):11-4. PubMed ID: 19351210
[TBL] [Abstract][Full Text] [Related]
11. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20.
Futamura M; Takagi Y; Koumura H; Kida H; Tanemura H; Shimokawa K; Saji S
J Surg Oncol; 1998 May; 68(1):34-40. PubMed ID: 9610661
[TBL] [Abstract][Full Text] [Related]
12. Occult tumor burden predicts disease recurrence in lymph node-negative colorectal cancer.
Hyslop T; Weinberg DS; Schulz S; Barkun A; Waldman SA
Clin Cancer Res; 2011 May; 17(10):3293-303. PubMed ID: 21307149
[TBL] [Abstract][Full Text] [Related]
13. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
[TBL] [Abstract][Full Text] [Related]
14. A splice variant of the transcript for guanylyl cyclase C is expressed in human colon and colorectal cancer cells.
Pearlman JM; Prawer SP; Barber MT; Parkinson SJ; Schulz S; Park J; Zook M; Waldman SA
Dig Dis Sci; 2000 Feb; 45(2):298-305. PubMed ID: 10711442
[TBL] [Abstract][Full Text] [Related]
15. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
Frick GS; Pitari GM; Weinberg DS; Hyslop T; Schulz S; Waldman SA
Expert Rev Mol Diagn; 2005 Sep; 5(5):701-13. PubMed ID: 16149873
[TBL] [Abstract][Full Text] [Related]
16. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer. effect of individual markers and tissue samples.
Salto-Tellez M; Kong SL; Leong AP; Koay ES
Eur J Cancer; 2003 Jun; 39(9):1234-41. PubMed ID: 12763211
[TBL] [Abstract][Full Text] [Related]
18. GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.
Mejia A; Schulz S; Hyslop T; Weinberg DS; Waldman SA
Expert Rev Mol Diagn; 2009 Nov; 9(8):777-85. PubMed ID: 19895223
[TBL] [Abstract][Full Text] [Related]
19. Does stage II colorectal cancer need to be redefined?
Grothey A
Clin Cancer Res; 2011 May; 17(10):3053-5. PubMed ID: 21498396
[TBL] [Abstract][Full Text] [Related]
20. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry.
Noura S; Yamamoto H; Ohnishi T; Masuda N; Matsumoto T; Takayama O; Fukunaga H; Miyake Y; Ikenaga M; Ikeda M; Sekimoto M; Matsuura N; Monden M
J Clin Oncol; 2002 Oct; 20(20):4232-41. PubMed ID: 12377967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]